A $3.4M grant funds research into how perimenopause hormonal changes may increase Alzheimer's risk in women, who face double ...

Only 12% of ~4,000 clinical prediction model studies share code, per Nature Medicine. FDA and NIH mandates exist, but ...

COA Integration With EDC is critical for CNS trials: disconnected systems trigger weeks of reconciliation work at database ...

ARPA-H grants $28.6M to build the largest protein aggregation dataset ever attempted, with 10 billion measurements to predict neurodegenerative disease onset.

Phase III trial of cadonilimab begins in perioperative colon cancer, testing dual PD-1/CTLA-4 blockade in MSI-H/dMMR patients ...

AI-driven automation reduces EDC query volume as trial complexity grows, collapsing configuration time from days to minutes across clinical trial networks.

Clinical data teams now prioritize AI validation and human oversight in regulatory workflows, following FDA guidance on ...

Tenax pauses LEVEL-2 enrollment to refine TNX-103 patient selection after the initial trial missed its primary walking ...

SYCUME met its Phase 3 primary endpoint for inactive thyroid eye disease, showing significant proptosis reduction versus ...

Sionna advances SION-451/SION-2222 combo into Phase 2a trial for cystic fibrosis, building on insights from prior SION-719 ...

Remibrutinib reduces relapse rates versus teriflunomide in Phase 3 MS trials REMODEL-1 and REMODEL-2, with results presented ...

Jupiter Neurosciences doses first Parkinson's patient in JOTROL Phase 2a trial, testing whether enhanced resveratrol achieves ...